Optimal replication of human cytomegalovirus correlates with endocytosis of glycoprotein gpUL132.
Envelopment of a herpesvirus particle is a complex process of which much is still to be learned. We previously identified the glycoprotein gpUL132 of human cytomegalovirus (HCMV) as an envelope component of the virion. In its carboxy-terminal portion, gpUL132 contains at least four motifs for sorting of transmembrane proteins to endosomes; among them are one dileucine-based signal and three tyrosine-based signals of the YXXØ and NPXY (where X stands for any amino acid, and Ø stands for any bulky hydrophobic amino acid) types. To investigate the role of each of these trafficking signals in intracellular localization and viral replication, we constructed a panel of expression plasmids and recombinant viruses in which the signals were rendered nonfunctional by mutagenesis. In transfected cells wild-type gpUL132 was mainly associated with the trans-Golgi network. Consecutive mutation of the trafficking signals resulted in increasing fractions of the protein localized at the cell surface, with gpUL132 mutated in all four trafficking motifs predominantly associated with the plasma membrane. Concomitant with increased surface expression, endocytosis of mutant gpUL132 was reduced, with a gpUL132 expressing all four motifs in mutated form being almost completely impaired in endocytosis. The replication of recombinant viruses harboring mutations in single trafficking motifs was comparable to replication of wild-type virus. In contrast, viruses containing mutations in three or four of the trafficking signals showed pronounced deficits in replication with a reduction of approximately 100-fold. Moreover, recombinant viruses expressing gpUL132 with three or four trafficking motifs mutated failed to incorporate the mutant protein into the virus particle. These results demonstrate a role of endocytosis of an HCMV envelope glycoprotein for incorporation into the virion and optimal virus replication.
Kropff
Barbara
B
Institut für Klinische und Molekulare Virologie, Schlossgarten 4, 91054 Erlangen, Germany.
Koedel
Yvonne
Y
Britt
William
W
Mach
Michael
M
D000595:Amino Acid Sequence; D000818:Animals; D002478:Cells, Cultured; D003587:Cytomegalovirus / Q000502:physiology*; D004705:Endocytosis / Q000502:physiology*; D005347:Fibroblasts / Q000166:cytology / Q000502:physiology / Q000821:virology; D006367:HeLa Cells; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism*; D008969:Molecular Sequence Data; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D014759:Viral Envelope Proteins / Q000235:genetics / Q000378:metabolism*; D014771:Virion / Q000235:genetics / Q000378:metabolism; D014779:Virus Replication
D008562:Membrane Glycoproteins; D011993:Recombinant Fusion Proteins; D014759:Viral Envelope Proteins; C551245:gpUL132 protein, human cytomegalovirus
EMBO J. 2002 Sep 16;21(18):4915-26
12234931
J Virol. 2002 Sep;76(18):9271-83
12186911
J Cell Sci. 2006 Oct 15;119(Pt 20):4235-46
16984970
Anal Biochem. 1998 Feb 1;256(1):137-40
9466810
J Virol. 2004 Nov;78(22):12406-15
15507627
J Virol. 2004 Oct;78(20):10960-6
15452216
J Virol. 2004 May;78(10):5279-87
15113909
J Virol. 2002 Jul;76(13):6845-51
12050399
J Cell Biol. 2005 Jan 31;168(3):477-88
15668298
J Virol. 2002 Feb;76(4):1537-47
11799148
J Virol. 2003 Apr;77(7):4191-204
12634377
Cell. 1991 May 31;65(5):895-903
1645620
Arch Virol. 1996;141(3-4):557-72
8645095
J Virol. 2004 Mar;78(6):2884-96
14990707
J Cell Biol. 2003 Dec 8;163(5):999-1010
14662744
J Virol. 2008 Apr;82(7):3490-9
18216124
J Virol. 2005 Feb;79(4):2160-70
15681419
J Virol. 1996 Jul;70(7):4253-60
8676446
J Virol. 2003 Oct;77(20):11105-13
14512558
J Virol. 1999 Oct;73(10):8320-9
10482582
J Virol. 2007 Dec;81(24):13889-903
17913800
J Virol. 1999 Apr;73(4):2717-28
10074118
J Virol. 1998 Jun;72(6):4571-9
9573220
J Gen Virol. 1977 Aug;36(2):345-9
197204
J Virol. 2002 Jan;76(2):591-9
11752150
PLoS Biol. 2006 Jun;4(6):e148
16646632
Mol Biol Cell. 2004 Aug;15(8):3542-52
15146059
J Virol. 2005 Jan;79(2):997-1007
15613328
J Virol. 1997 May;71(5):4042-54
9094682
J Virol Methods. 1989 Feb;23(2):157-67
2542350
J Exp Med. 2006 Aug 7;203(8):1843-50
16831899
Nat Struct Biol. 2003 May;10(5):386-93
12679809
J Virol. 2000 Jan;74(2):975-86
10623760
J Virol. 2004 Aug;78(16):8852-9
15280493
J Virol. 2005 Jun;79(11):7248-54
15890963
Histochem Cell Biol. 2008 Mar;129(3):267-76
18193449
Nucleic Acids Res. 1999 Mar 15;27(6):1555-7
10037821
Gene. 1995 May 26;158(1):9-14
7789817
J Virol. 2007 Oct;81(19):10316-28
17626081
J Virol. 2003 Mar;77(5):3191-203
12584343
J Virol. 2002 May;76(10):5147-55
11967330
Traffic. 2009 Oct;10(10):1439-57
19761540
Annu Rev Biochem. 2003;72:395-447
12651740
J Biol Chem. 1998 May 29;273(22):13430-6
9593675
J Virol. 2004 Feb;78(3):1540-51
14722308
J Virol. 2002 Aug;76(16):8208-17
12134026
Curr Opin Microbiol. 2006 Aug;9(4):423-9
16814597
J Virol. 1999 May;73(5):4372-84
10196335
Mol Cell Biol. 1991 Jan;11(1):143-53
1846020
J Virol. 2007 May;81(10):5212-24
17229708
J Virol. 2005 Sep;79(18):11837-47
16140760
J Biol Chem. 1998 Oct 2;273(40):25915-21
9748267
Eur J Cell Biol. 2004 Jul;83(6):257-62
15511083
J Gen Virol. 1987 Jul;68 ( Pt 7):1897-907
3037013
J Clin Virol. 2000 Aug;17(2):69-82
10942087
Microbiol Mol Biol Rev. 2008 Jun;72(2):249-65, table of contents
18535146
J Virol. 1999 Oct;73(10):8677-88
10482621
J Virol. 2000 Aug;74(15):7137-45
10888654